Signatories

President of France, Jacques Chirac and the Director General of UNESCO , Kōichirō Matsuura.


For the 4th of February 2000 Summit, 156 dignitaries from 27 countries travelled from across the globe to sign the Charter of Paris Against Cancer.

Last NameFirst NameCountryBiography
ChiracJacquesFrance View
MatsuuraKoichiroJapan View
TiberiJeanFrance View
Princess ChulabhornThailand View
LederbergJoshuaUSA View
GianniLucaItaly View
HollandJimmie C.USA View
HongWaun KiUSA View
MendelsohnJohnUSA View
SimoneJosephUSA View
FisherBernardUSA View
PinedoHerbertNetherlands View
ViscoFrances M.USA View
AaproMaati S.Switzerland View
RobinsonEliezerIsrael View
ErnsterVirginiaUSA
Zur HausenHaraldGermany View
KripkeMargaret L.USA View
WoolamGeraldUSA View
TannockIan F.Canada View
HarperPeterUnited Kingdom View
CoatesAlan S.Australia View
HoriotJean-ClaudeFrance View
MontesanoRuggeroFrance
CaveneeWebster K.USA View
HollandJames F.USA View
HortobagyiGabriel N.USA
KhayatDavidFrance View
BenjaminRobert S.USA View
CroceCarlo M.USA View
De La GarzaJaimeMexico View
DesalvaAnnaMariaUSA View
EinhornLawrence H.USA View
FidlerIsaiah J.USA View
FotiMargaretUSA View
PiccartMartineBelgium View
TaguchiTetsuoJapan
TemperoMargaretUSA View
AbeloffMartin D.USA View
AjaniJafferUSA View
ArmitageJames O.USA View
AuclercGerardFrance
AzimHamdy A.Egypt View
BailletFrancoisFrance
BaselgaJoseSpain View
BastRobertUSA View
Ben AriGurIsrael
Benitez-BribiescaLuisMexico View
BertinoJosephUSA View
BismuthHenriFrance View
BleibergHarryBelgium View
BloomfieldClara D.USA View
BrinkerNancyUSA View
BugatRolandFrance
BunnPaulUSA View
BuzaidAntonioBrazil View
CaiWeimingChina
CalvertA. HilaryUnited Kingdom View
CanellosGeorge P.USA View
CascinelliNataleItaly View
CazapEduardoArgentina View
ChristensenLillyNorway
CocconiGiorgioItaly View
ColvinMichael O.USA View
ComisRobert L.USA View
ConstenlaManuelSpain View
Cortes FunesHernanSpain View
CurranTomUSA View
Dalla FaveraRiccardoUSA View
DaussetJeanFrance View
Diaz RubioEduardoSpain View
DoniniIpolitoItaly View
EarpShelton H.USA View
EggermontAlexanderNetherlands View
EichholtzGabrielle
EllisPaulUnited Kingdom View
EngstromPaulUSA View
ErnstorfMarc S.USA View
EschwegeFrancoisFrance View
EstevezRobertoArgentina View
FernandezOscar
Frei IIIEmilUSA View
FreilichGloriaUnited Kingdom View
FreireichEmilUSA View
FreueJose MarioArgentina
FujimotoShigeruJapan
GeorgouliasVassilisGreece View
GermaJose RamonSpain View
GoldhirschAronSwitzerland View
GoldmanDavidUSA View
Gombe M'BalawaCharlesCongo View
GouveiaJoaquimPortugal View
GriscelliClaudeFrance View
HossfeldDieterGermany View
HuthPierreFrance
IchikawaHeizaburouJapan
IsraelLucienFrance View
IzraelVictorFrance View
JanickeFritzGermany View
JasminClaudeFrance View
JordanV. CraigUSA View
KemenyNancyUSA
KozelskaJanaCzech Republic
LabrieFernandCanada View
LartigauEricFrance View
Le ChevalierThierryFrance View
LederbergMargueriteUSA View
LichinisterMichaelFrance
LucasMichelFrance
MartinMiguelSpain
MartyMichelFrance
McCormickFrankUSA
McVieGordonUnited Kingdom
MerlanoMarcoItaly
MisraN.C.India
NamerMoiseFrance
NataliPier GiorgioItaly
NathanDavid G.USA
NizriDanielFrance
NortonLarryUSA
O'ConnellMichaelUSA
O'HigginsNiallIreland
OzolsRobert F.USA
Perez MangaGumersindoSpain
PetersWilliam P.USA
PhilipThierryFrance
PouillardPierreFrance
RichardsMichaelUnited Kingdom
RosenStevenUSA
RouesseJacquesFrance
RowleyDonaldUSA
RuanChanggengChina
RussellKathyUSA
RuizDan
SchilskyRichardUSA
SchmilovichAndresArgentina
SchneiderMauriceFrance
SerinDanielFrance
SoubraneClaudeFrance
StovalHelene
TaharaEiichiJapan
TancaValentino
ThomasHilaryUnited Kingdom
TubianaMauriceFrance
TurszThomasFrance
UntchMichaelGermany
Von EschenbachAndrew C.USA
WagenerTheoNetherlands View
WeilMariseFrance
Whang PengJacquelineTaiwan
WichaMax S.USA
WieselElieUSA
WinninghamRickUSA
WolmarkNormanUSA
WuCheng-WenTaiwan
ZalcbergJohnAustralia

Jacques René Chirac was a French politician who served as President of France from 1995 to 2007. Chirac was previously the Prime Minister of France from 1974 to 1976 and from 1986 to 1988, as well as the Mayor of Paris from 1977 to 1995.

 

Kōichirō Matsuura is a Japanese diplomat. He was the Ambassador of Japan to Paris from 1994 to 1999. At which time, he became Director-General of UNESCO; a position he held from 1999 until 2009.

Jean Tiberi was mayor of Paris from 1995 to 2001. He was among the longest-serving members of the National Assembly of France, in which he has served 10 terms and 44 years, deciding not to run for reelection in 2012.

Professor Dr. Princess Chulabhorn of Thailand is founding President of the Chulabhorn Research Institute (CRI). Her royal highness established the first comprehensive cancer centre in Thailand within CRI. She is the recepient of many awards, including UNESCO’s Einstein Medal for her continuous effort in promoting scientific collaboration in Asia and the Pacific.

Joshua Lederberg (May 23, 1925 – February 2, 2008) was an American molecular biologist known for his work in microbial genetics, artificial intelligence, and the United States space program. He won the 1958 Nobel Prize in Physiology or Medicine for discovering bacterial conjugation. He shared the prize with Edward Tatum and George Beadle, who won for their work with genetics. He also did extensive research in artificial intelligence, including his work for NASA seeking life on Mars and his work on the chemistry expert system Dendral.

Dr. Gianni is the Director of the Department of Medical Oncology at the San Raffaele Scientific Institute in Milan, Italy. He also is the Cofounder and President of the Michelangelo Foundation, a non-profit organization designed to advance research in oncology, and chairman of the Michelangelo Breast Cancer Study Group. Recently Dr. Gianni also became the first President of the “Gianni Bonadonna Foundation” for innovative therapies for cancer. During his career Dr. Gianni has worked on new drug development in the field of oncology and on the definition of innovative drug therapies in Medical Oncology. Since 1995 he focused on clinical and translational research in women with breast cancer.

Jimmie C. Holland (April 9, 1928 – December 24, 2017) was an American psycho-oncologist and medical researcher. She aided in creating the Psychiatric Service for New York’s MSK Cancer Center. She wrote the first psycho-oncology syllabus, as well as being the senior editor of its first textbook. In 1980, she founded the American Psychosocial Oncology Society. She is credited with being the reason for psychosocial and behavioral research being added to the American Cancer Society’s agenda.

Waun Ki Hong (August 13, 1942 – January 2, 2019) was a South Korean physician-scientist who worked at MD Anderson Cancer Center in Texas. He was also a Professor for the American Cancer Society. He’s known for having shown that the destruction of organs wasn’t necessary for treatment. Moreover, he proved that it is possible to precisely target tumors.

John Mendelsohn (August 31, 1936 – January 7, 2019) was molecular biologist and oncologist. He served as President to the University of Texas MD Anderson Cancer Center for 15 years (1996-2011), after which he became co-director of MD Anderson’s Institute for Personalized Cancer Therapy until his retirement.

Joseph Simone (1935) was an American pediatric oncologist who was awarded the ASCO/American Cancer Society Award in 2010. He helped in developing the first curative treatments for childhood leukemia and lymphoma. He also created a Disease Management Program which eventually led to the development American Society of Clinical Oncology’s Quality Oncology Practice Initiative.

Bernard Fisher (August 23, 1918 – October 16, 2019) was an American surgeon who helped pioneer the treatment of breast cancer. His discoveries led to a great improvement in breast-cancer survival rates across the globe. He was awarded a Medal of Honor from the American Cancer Society in 1986.

Professor Herbert Pinedo (1943) is a Dutch oncologist and founder of the NDDO-Oncology (New Drug Development Organization-Oncology) in Amsterdam. Moreover he was the first President of the Federation of European Cancer Societies as well as a past President of the European Society of Medical Oncology. He worked primarily on cancer chemotherapy and drug resistance in cancer.

Frances M. Visco was the first President of the National Breast Cancer Coalition (NBCC). In 1993 she was appointed as one of the three members of President Clinton’s Cancer Panel; she served three terms in this position.

Dr. Matti Aapro is an oncologist. He has and continues to serve on many boards. He is a member at the management level of ESO (European School of Oncology) and SIOG (International Society for Geriatric Oncology). He is the president of the European Cancer Organization for 2020-2022. He was a member of the board of the European Organization for Research and Treatment of Cancer (EORTC) and president of the MASCC (Multinational Association for Supportive Care in Cancer). He was also a member of the executive board of ESMO (European Society for Medical Oncology). He has published over 300 articles in peer-reviewed journals

Professor Eliezer Robinson is an oncologist. He is Professor Emeritus of the Faculty of Medicine of Technion in Haifa. He has served and continues to serve within many organizations; including having served as Vice-President of the Israeli Cancer Association (ICA) from 1971 to 1995; in 1996 he was appointed Chairman of the ICA. He has also served as the President of the Union for International Cancer Control.

Professor Harald zur Hausen is a German virologist and professor emeritus. He has received a number of awards, including the the Nobel Prize in Physiology or Medicine 2008 for his research on cancer of the cervix, where he discovered the role of papilloma viruses. He has 33 honorary doctorates.

Margaret L. Kripke is a professor of immunology and the executive vice president and chief academic officer at M. D. Anderson Cancer Center. She is an expert in photoimmunology and the immunology of skin cancers; she earned a Ph.D in immunology at the University of California at Berkeley. She served three terms on the President’s Cancer Panel, which oversees the development and implementation of the National Cancer Program. MD Anderson established the Margaret Kripke Legends Award, in honor of her work, to be awarded annually to individuals whose support and dedication have enhanced the careers of women in cancer medicine and cancer science.

Gerald Woolam was an American surgeon and professor at Texas Tech University School Medicine. He was also chief medical officer at Southwest Life and Health/Firstcare up until his retirement in 2017. He was awarded both the Marquis Humanitarian Award and the Albert Nelson Marquis Lifetime Achievement Award.

Ian F. Tannock is a Canadian Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre and University of Toronto. He chaired trials for men with metastatic prostate cancer that led to licensing of previous and current standard chemotherapy. He was also a member of the Board of Directors of the American Society of Clinical Oncology and, in December 2013, he was appointed as a Member of the Order of Canada.

Dr Peter Harper is a leading consultant at Guy’s and St Thomas Hospital. He is a founding partners of the London Oncology Clinic. He has over 400 peer reviewed publications.

He has been the chair, or has been a member of many international executive committees investigating new approaches to cancer treatment, editorial boards for professional publications.

He holds the prestigious Cino del Duca Medal.  He is a member of the Chevalier of the Legion D’Honneur. He is on the board of INCA, the strategic committee for cancer treatment in France, and is Chairman of the Toulouse Cancer Centre and holds the Medaille D’Or of that city.

Alan Coates is an Australian professor of clinical oncology, medical researcher and administrator. He was the inaugural CEO of the Cancer Council Australia (1998–2006), former president of the Clinical Oncological Society of Australia (COSA), and co-chair of the St. Gallen International Breast Cancer Conference. He was also the first non-American to be elected to the Board of Directors of the American Society of Clinical Oncology.

Jean-Claude Horiot is a French doctor, currently stationed at the Radiation oncologist Institute Multidisciplinary Oncologie in Switzerland, who specializes in radiation oncology and radiotherapy.

Webster Cavenee is the Director of Strategic Alliances in Central Nervous System Cancers at the Ludwig Institute for Cancer Research and Distinguished Professor at the University of California, San Diego. He is largely credited with providing the first indisputable evidence of the existence of tumor suppressor genes. Throughout his career, Dr. Cavenee has published more than 300 publications and has been recognized with more than 80 honors and awards

James F. Holland (May 16, 1925 – March 22, 2018) was an American physician. In 1953, his clinical trial on acute leukemia eventually resulted in the formation of the Cancer and Leukemia Group B research collaboration. He served as president for both the American Association for Cancer Research and the American Society of Clinical Oncology.

Professor David Khayat is the Head of the Department of Medical Oncology at the Pitié-Salpêtrière Hospital.  He is a professor of oncology at the University Pierre and Marie Curie and adjunct professor at MD Anderson Cancer Center. He was instrumental in organizing the World Summit against Cancer and the Charter of Paris against Cancer.  He organized and was the first president of the French Federation of Medical Oncologists (FFOM). He created the Association pour la Vie – Espoir contre le Cancer [Life Association – Hope against Cancer] (AVEC). He has served on several editorial boards, including Cancer and Journal of Internal Medicine.  He has over 500 peer reviewed publications.

He is chevalier of the National Order of Merit, of the Legion of Honor, of the Order of Sainte Agathe, and the Academics Palms. He is Commander of the Order of the British Empire (CBE), Chevalier de l’ordre du Lion du Sénégal, and officer in the Russian order of the friendship between people.

Robert S. Benjamin is an American Professor in the Department of Sarcoma Medical Oncology at MD Anderson Cancer Center. He conducted studies which led to the establishment of chemotherapy treatments sarcoma. He was also awarded LifeRaft Society’s Humanitarian Award in 2004.

Carlo M. Croce is an Italian physician stationed in the USA who is known for his research of cancer pathogenesis. He showed that there chromosomal abnormalities can contribute to both cancer initiation and progression. Moreover, he proved that particular micro RNAs could exhibit either oncogenic or tumor suppressive properties.

Jaime De La Garza is known as the pioneer of medical oncology in Mexico. He is both the executive secretary of the Science Advisory Council for the President of the Mexican Republic and a research investigator at Tlalpan’s Instituto Nacional de Cancerología. Moreover, he helped found the SLACOM (Latin American and Caribbean Society of Medical Oncology). Furthermore, he helped found and served as President for the Mexican Oncology Board.

AnnaMaria DeSalva is the Chairman and CEO of Hill+Knowlton Strategies – a public relations and communications firm. She is also Vice Chairman of the Board at XPO Logistics. Moreover she is a member of the Board of Governors of Argonne National Laboratory – one of the US Department of Energy’s science and engineering research laboratories.

Lawrence H. Einhorn is an American oncologist who developed cisplatin-based chemotherapy regimens which decreased toxic side effects while increasing cure rates.

Isaiah J. Fidler (December 4, 1936 – May 8, 2020) was born in Israel but was stationed as a professor and founding chair of the Department of Cancer Biology at MD Anderson until 2008. Along with being a pioneer in the field of cancer metastasis, he was also a President of the AACR (American Association for Cancer Research).

Margaret Foti is the chief executive officer of the American Association for Cancer Research (AACR). She also integrated the Women in Cancer Research (WICR) into the AACR and is on its Council.

Martine Piccart is a Belgian professor at ULB and is scientific director at the Jules Bordet Institute in Brussels. She co-founded the Breast International Group (BIG) in 1996 and is currently its Immediate Past Chair and well as President of BIG against breast cancer.

Margaret Tempero is an American gastrointestinal oncologist. She is the director of the UCSF Pancreas Center and leader of the Pancreas Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center. Additionally, she helped pioneer the application radioactively tagged antibodies for cancer therapy.

Dr. Martin Abeloff joined the faculty of the Johns Hopkins University School of Medicine in 1972. He served as director of the Cancer Center from 1992 to 2007. He held an American Cancer Society Clinical Professorship since 1991. He served as President of the American Society of Clinical Oncology in 1991-92 and as Chairman of the Oncology Drug Advisory Committee of the FDA. He was former Chairman of the Board of Scientific Counselors to the NCI’s Intramural Division of Clinical Sciences at the National Cancer Institute and a member of its executive committee. He also held many editorial responsibilities, including associate editor of the Journal of Clinical Oncology, editor of Current Opinion in Oncology, and was one of four editors of a comprehensive textbook in oncology, Clinical Oncology.

Ajani Jaffar is an Indian Professor in the Department of Gastrointestinal Medical Oncology at MD Anderson. He chairs the NCCN committee for gastroesophageal cancers. Moreover, he is the editor of ISGIO’s journal Gastrointestinal Oncology Research.

James O. Armitage is an American Professor of Medicine. In 1979 he directed the Bone Marrow Transplantation Program. From 1982 to 1990 he served as Vice Chairman of the Department of Medicine, and from 1986 to 1989 he was Chief of the Division of Oncology/Hematology, before continuing on to be Chairman of the Department of Internal Medicine from 1990 to 1999 in Nebraska. He has also served as both President of ASCO (1996-97) and President of ASBMT (2000-01).

Hamdy A. Azim an Egyptian oncologist. He is Chairman of KASO (Kasr Al-Ainy School of Oncology) and Professor of Clinical Oncology at Cairo University. Moreover, he is the President of Africa Middle East Cancer Research Inter group. From 1997 to 2002, he was the first to represent the Middle East countries on the ASCO international committee. He signed Charter of Paris against Cancer on behalf of the Arab World in February 2000.

Jose Baselga is a Spanish oncologist who researched the development of novel molecular targeted agents, particularly in relation to breast cancer. He served as Physician-in-Chief at the Memorial Sloan Kettering Cancer Center until September 2018.

Robert Bast is an American oncologist at MD Anderson where he serves as Vice President for Translational Research, Internist and Profess of Medicine, and Harry Carothers Wiess Distinguished University Chair for Cancer Research.

Luis Beítez-Bribiesca (July 14, 1934 – November 30, 2015) was a Mexican pathologist. He was a member of the editorial board of the Journal of Cancerology and was also Member of the Governing Board of the National Cancer Institute. He was the Direct of the Master of Medical Physics program at UNAM (National Autonomous University of Mexico) and author of the book “Uno Ruta Hacia la Ciencia. La Preparación de un Científico.”

Joseph Bertino is an American professor of medicine and pharmacology at the Robert Wood Johnson Medical School as well as a researcher in the cancer pharmacology program at Rutgers Cancer Institute of New Jersey. He specializes in the treatment of lymphoma.

Henri Bismuth is a French surgeon, born in Tunisia. He is a pioneer of hepatobiliary surgery and liver transplantation. He contributed to the development of multiple new transplantation techniques such as the use of partial livers which revolutionized pediatric liver transplantation by giving children access to adult grafts, and the development of the split technique, allowing two patients to be transplanted with a single liver.

Harry Bleiberg is a Belgian internist oncologist. He works in academia as head of the gastroenterology clinic at the Jules Bordet Institute, ULB, Brussels and developed the oncology clinical research at the international level at the EORTC. He is currently working as a consultant in research and development of anticancer drugs and devices for the diagnosis of cancer.

Clara D. Bloomfield (May 15, 1942 – March 1, 2020) was an American physician and cancer researcher. She helped identify several novel chromosome changes in leukemia and lymphoma, and discovered that these abnormalities are among the most important factors that determine a patient’s prognosis. Moreover, she co-authored the WHO (World Health Organization) Classification of Tumors of Hematopoietic and Lymphoid Tissues, and the European LeukemiaNet (ELN) guidelines on diagnosis and management of acute myeloid leukemia

Nancy Brinker is currently WHO’s Goodwill Ambassador for Cancer Control. She is the founder of the Promise Fund, as well as the United States Ambassador to Hungry from 2001 to 2003. She was also Chief Protocol of the United States from 2007 to 2009. She was honored with the Presidential Medal of Freedom on August 12, 2009.

Paul Bunn is an American oncologist. He is a founding director of the University of Colorado Cancer Center, as well as a past president of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO). Moreover, he served as chairman of the FDA Oncology Drug Advisory Committee.

Antonio Buzaid is a Brazilian oncologist who aided in creating the Oncology Center of the hospital Sírio Libanês in 1998. From then until 2010 he served as Director of said Oncology Center, and in 2011 he becae General Medical Director of the Oncology Center Antonio Ermírio de Moraes de Beneficência Portuguesa of São Paulo. Finally in 2015, he became a member of the management committee of the Oncology Center of Hospital Israelita Albert Einstein.

Hilary Calvert is an English Professor who serves as Director of Cancer Drug Discovery and Development at the UCL Cancer Institute. He developed the Calvert Formula and made advances in anti-cancer drug development, for which he was awarded the Pfizer Research Innovation Award in 2005.

George P. Canellos is an American oncologist and cancer researcher. He is known for aiding the create CMF (one of the first combination therapies for breast cancer) and the MOPP regimen for Hodgkin’s lymphoma. He served as chair of the Lymphoma Committee of the Cancer and Leukemia Group B (CALGB) and is currently the William Rosenberg Professor of Medicine at Harvard Medical School.

Natale Cascinelli (1939 – April 2, 2013) was an Italian oncologist and melanoma scholar. He was an expert on the Superior Health Council and was associate director of Oncological Surgery for the National Institute for the study and treatment of tumors in Milan. He was then scientific director from 1998 to 2006. Moreover, he was in charge of the World Health Organization’s (WHO’s) Melanoma Program.

Eduardo Cazap is Argentinean and the founder and first President of the Latin American & Caribbean Society of Medical Oncology (SLACOM) since 2004. In 2009 he was elected Board Member of the American Society of Clinical Oncology (ASCO-Alexandria) to represent the international members. Finally, he was nominated a member of the Board of Directors of the newly created National Cancer Institute of Argentina in September 2010.

Giorgio Cocconi is an Italian oncologist who established the Medical Oncology Unit of Parma in 1974.

Michael O. Colvin (August 31, 1936 – March 16, 2013) was an American oncologist and director emeritus of the Duke Comprehensive Cancer Center and the William W. Shingleton Professor of Cancer Research. He worked on developing stem cell therapies and was one of the first investigators to use high-dose cyclophosphamide to treat solid tumors, which is now a common practice in bone marrow transplantation for breast and other cancers. Moreover, he was a co-leader of the Duke Cancer Center’s Experimental Therapeutics Research Program.

Robert L. Comis (1946 – May 10, 2017) was an American researcher who focused primarily on lung cancer and developmental therapeutics. He built cancer research and treatment centers in Syracuse, at Fox Chase Cancer Center, and Thomas Jefferson University in Philadelphia. Moreover, he was Chair of the Eastern Cooperative Oncology Group (ECOG) and led it from 1995 to 2012. He also envisioned the merger that resulted in the ECOG-ACRIN Cancer Research Group in 2012.

Manuel Constenla is a Spanish oncologist and Head of the Medical Oncology Service at the Hospital Montecelo de Pontevedra. He serves on the editorial boards of several Spanish professional journals.

Hernán Cortés-Funes is an Argentinean doctor and was a member of the Spanish Society of Medical Oncology (Spanish SEOM), as well as President of the European Society of Medical Oncology (ESMO). He was also President of the Federation of European Cancer Societies (FECS) and of the Spanish Association of Cancer Research.

Tom Curran is a Scottish medical researcher and Executive Director and Chief Scientific Officer of the Children’s Mercy Research Institute in Kansas City, Missouri. He was Chairman of the Department of Developmental Neurobiology at St. Jude Children’s Research Hospital, and was also President of the American Associate for Cancer Research (AACR) in 2000, and is currently a member of the Institute of Medicine.

Riccardo Dalla Favera is an American Professor Pathology and Cell Biology. He is also both the Director of the Institute for Cancer Genetics, and the Director of the Specialized Center for Research on Lymphoma at Columbia University. He was awarded the Burkitt Medal in 2015 and currently holds the Joanne and Percy Uris Chair of Clinical Medicine.

Jean Dausset (October 19, 1916 – June 6, 2009) was a French immunologist. In 1980, due to his, Baruj Benacerraf, and George Devis Snell’s discovery and characterization of the genes making the major histocompatibility complex, he was awarded the Nobel Prize in Medicine. Following this, in 1984, he founded the Human Polymorphism Study Center (CEPH), which was later renamed the Foundation Jean Dausset-CEPH in his honor.

Eduardo Diaz Rubio is a Spanish oncologist who, in 2017, was appointed Emeritus Professor of the Complutense University of Madrid, as well as Emeritus Oncologist of the Madrid Health System. In 1986 he founded the TTD (Spanish Group for the Treatment of Digestive Tumors) and remained its President until 2004. From 2003 to 2008, he had been responsible for the Integral Plan Against Cancer. Moreover, in 2005, he was appointed Spanish representative in the World Organization for Health in Cancer, as well as for the European Alliance Against Cancer.

Ipolito Donini (1929 – 2013) was an Italian surgeon and from 1999 to 2003 was Rector of the University of S. Marino. From 1970 to 1995, he was the Director of the Clinical Institute of the University of Ferrara. From 1996 to 1999, he directed the Department of Biomedical Sciences and Advanced Therapies, and from 2000 to 2004, he directed the Department Surgical Anesthesiology and Radiology Sciences

Shelton H. Earp is an American physician and is the Director of the UNC Lineberger Comprehensive Cancer Center. Moreover, he is also the Director for UNC Cancer Care, the Lineberger Professor of Cancer Research, and Professor in the Departments of Medicine and Pharmacology. 

Alexander Eggermont is a Dutch oncologist and surgeon at the Princess Máxima Center for Pediatric Oncology in Utrecht. From 1988 to 2011, he was Chief Surgeon at the Daniel den Hoed cancer center. Moreover, in 2015 he became a Knight of the French Legion of Honor.

Paul Ellis is a Professor of Cancer Medicine at King’s College London. He is also Guy’s & St Thomas’ Hospital’s Consultant Medical Oncologist, where he has served as Head of Medical Oncology and Head of Breast Cancer Clinical Research. Furthermore, he helped chair the UK Dept of Health Advisory committee on the introduction of Herceptin into UK clinical practice

Paul Engstrom is an American medical oncologist and Professor Emeritus in the Department of Hematology/Oncology at Fox Chase Cancer Center. He is currently chair of the National Comprehensive Cancer Network (NCCN) Colorectal-Anal Cancer Guidelines Panel, as well as a member of the NCCN Neuroendocrine Malignancy Panel and Senior Adult Oncology Task Force.

Marc S. Ernstorf is an American is Professor and Chief of the Division of Hematology/Oncology in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, New York. He is also Chair of the Department of Medicine and Senior Vice President of Clinical Investigation at Roswell Park Cancer Institute (RPCI). Moreover, he became the Director of the Melanoma Program at Cleveland Clinic’s Taussig Cancer Institute in 20014.

Francois Eschwege is a French doctor, President of the Centre Antoine Béclère in Paris and elected Foreign Correspondent in 2000. In 1996, he was promoted to Chevalier de la Légion d’Honneur and since 1981 he has also been a member of the executive board of the European Association of Radiology.

Roberto Estevez is an Argentinean oncologist and both the founder and first President of the Latin American and Caribbean Society of Medical Oncology (SLACOM). From 2008 to 2010 he served as President of the International Union against Cancer (UICC).

Emil Frei III (February 21, 1924 – April 30, 2013) was an American physician and oncologist and Director and Physician-in-chief of the Dana-Farber Cancer Institute in Boston. He was also Harvard Medical School’s Richard and Susan Smith Distinguished Professor of Medicine. While at M.D. Anderson, between 1965 and 1972, he was the founding director of the Department of Development Therapeutics, which evolved into the Clinical Research Center. Moreover, he was one of the founders of the Acute Leukemia Group B which later became the Cancer and Leukemia Group B (CALGB).

Gloria Freilich is English and the founder and President of Europa Donna – the European Breast Cancer Coalition, Europe’s first breast cancer advocacy organization. She is also coordinating director of Cancerkin, a hospital-based
breast cancer charity in London

Emil Freireich (March 16, 1927 – February 1, 2021) was an American oncologist, hematologist, and cancer biologist. He helped pioneer the treatment of cancer, the use of chemotherapy, and modern leukemia therapy.

Vassilis Georgoulias is a Greek oncologist and Professor Emeritus in Medical Oncology at the University of Crete. He is also the First Department of Medical Oncology at IASO General Hospital in Athens, as well as Chairman Chairman of the Hellenic Oncology Research Group (HORG).

Jose Ramon Germa is a Spanish oncologist and the Director of Knowledge Management and Head of the Medical Oncology Service at the Catalan Institute of Oncology at the University of Barcelona. He has also served as President of the Spanish Society of Medical Oncology and Spanish representative in the European Society of Medical Oncology.

Aron Goldhirsch (1946 – February 26, 2020) was a founder of both the Breast International Group (BIG) and of the International Breast Cancer Study Group (IBCSG).

David Goldman is an American Professor of Oncology at Albert Einstein College of Medicine. He is also a Professor in the Department of Molecular Pharmacology, as well as Susan Resnick Fisher Chair in Brain Cancer Research.

Charles Gombe M’Balawa is a Congolese oncologist and was Head of the Oncology Department at the General Hospital of Brazzaville. In 2017 he became the Head of ALIAM.

Joaquim Gouveia (1943 – 2019) was a Portuguese hematologist and oncologist as well as Director of the Portuguese Institute of Oncology in Lisbon Francisco Gentil (IPO Lisboa) between 1998 and 2001. He founded the Oncology Service at the CUF Hospital Descobertas and became a clinical director. Moreover, between 2006 and 2008 he was National Coordinator for Oncological Diseases.

Claude Griscelli is a Moroccan Professor, pediatrician, and immunologist in France. He served as General Director of INSERM and President of the Institute of Genetic Diseases, then State Counselor.

Dieter Hossfeld is a German Professor of Internal Medicine and Director of the Department of Oncology-Hematology at the University of Hamburg.

Lucien Israel (April 14, 1926 – June 9, 2017) was a French oncologist and neurology specialist. He was President of the Academy of Moral and Political Sciences in 2007. He was also a vice-president of the National Inter-University Union (UNI) and was made Commander of the Order of the Legion of Honor and of the National Order of Merit.

Victor Izrael is a French oncologist and Knight of the Legion of Honor. In 1985, he created the Medical Oncology Department at Tenon Hospital, and in 1989, with the help of Dr Nicole Bru, he founded APREC (Alliance for Cancer Research), which he still currently directs and chairs. Additionally, in 2002, he was one of the fathers of the French Cancer Plan.

Fritz Janicke is a German gynecological oncologist, senologist, and endocrinologist at Medizinicum Centre for Internal Medicine in Nienstedten.

Claude Jasmin (December 12, 1938 – August 19, 2017) was a French professor of oncology and Head of the hematology, immunology and tumor biology department, Paul-Brousse hospital from 1982 to 2004. He was also founder and President of the International Council for Global Health, as well as founding President of the International Society for Bone Metastases in 1999. Moreover, from 1999 to 2002, he was President of the Institute of Cancer and Immunogenetics.

Virgil Craig Jordan is an American pharmacologist who is specialized in breast cancer treatment and prevention. He is currently Professor of Breast Medical Oncology, and Professor of Molecular and Cellular Oncology at the University of Texas MD Anderson Cancer Center. He was the first to discover the breast cancer prevention properties of tamoxifen and the scientific principles for adjuvant therapy with antihormones.

Fernand Labrie is a Canadian endocrinologist. In fact, in 1969, he founded the first Molecular Endocrinology Research Laboratory in the world, at Laval University. From 1990 to 2002, he was also Head of the Department of Physiology and Anatomy at the Laval University Faculty of Medicine, as well as President of the FRSQ (Fonds de la recherche en santé du Québec) from 1992 to 1995. Moreover, he was President of both the Canadian Society of Endocrinology and Metabolism (1978-1979) and of the Canadian Society of Clinical Investigation (1992-1996).

Eric Lartigau is a French oncologist-radiotherapist, professor, and currently General Director of the Oscar Lambret Center. He was also President of the French Society of Oncological Radiotherapy from 2009 to 2011.

Thierry Le Chevalier is a French medical oncologist and Head of the Institute of Thoracic Oncology at Gustave Roussy Hospital. He is an expert in therapeutic strategies and translational research for lung cancer.

Marguerite Lederberg (1937 – February 16, 2020) was a French oncologist, stationed in the USA. She was a pioneer in the fields of supportive care and psycho-oncology – having even founded the first Psycho-Oncology Program. She also founded the International Psycho-Oncology Society (IPOS) alongside Jimmie C. Holland.

Biography for Theo Wagener coming shortly.